Evaluating the Prognostic Value of microRNA-203 in Solid Tumors Based on a Meta-Analysis and the Cancer Genome Atlas (TCGA) Datasets
Open Access
- 24 March 2017
- journal article
- research article
- Published by S. Karger AG in Cellular Physiology and Biochemistry
- Vol. 41 (4) , 1468-1480
Abstract
Background: It has been reported that miR-203 expression was aberrant in various types of cancers, and it could be used as a prognostic biomarker. Therefore, in this study, we aimed to evaluate the prognostic value of miR-203 expression in solid tumors by using meta-analysis and The Cancer Genome Atlas (TCGA) datasets. Methods: By doing a literature research in PubMed, Embase and the Cochrane Library (last update by December 2016), we were able to identify the studies assessing the prognostic role of miR-203 in various tumors. We then used TCGA datasets to validate the results of meta-analysis. Results:33 studies from 26 articles were qualified and enrolled in this meta-analysis. Pooled analyses showed that higher expression of miR-203 in tissues couldn’t predict poor overall survival (OS) and progression-free survival (PFS) in solid tumors. However, the results of subgroup analyses revealed that the upregulation of tissue miR-203 expression was associated with poor OS in colorectal cancer (hazard ratio (HR)=1.81, 95% confidence intervals (CI) 1.31-2.49; PPPP=0.040) and esophageal cancer (HR=0.41, 95% CI 0.25-0.66; PConclusion: Our study showed that the prognostic values of tissue miR-203 varied in different tumor types. In addition, the upregulation of circulating miR-203 in blood was associated with poor prognosis in colorectal cancer and breast cancer.Keywords
This publication has 46 references indexed in Scilit:
- Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancerGastric Cancer, 2015
- MicroRNA‐203 down‐regulation is associated with unfavorable prognosis in human gliomaJournal of Surgical Oncology, 2013
- MiR‐182 and miR‐203 induce mesenchymal to epithelial transition and self‐sufficiency of growth signals via repressing SNAI2 in prostate cellsInternational Journal of Cancer, 2013
- Prognostic MicroRNAs in Cancer Tissue from Patients Operated for Pancreatic Cancer—Five MicroRNAs in a Prognostic IndexWorld Journal of Surgery, 2012
- miR-203 expression predicts outcome after liver transplantation for hepatocellular carcinoma in cirrhotic liverMedical Oncology, 2011
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survivalInternational Journal of Cancer, 2009
- Youden Index and Optimal Cut‐Point Estimated from Observations Affected by a Lower Limit of DetectionBiometrical Journal, 2008
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon AdenocarcinomaJAMA, 2008
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002